Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study
Hao Xing(Second Military Medical University), Tian Yang(Second Military Medical University), Wanguang Zhang(Tongji Hospital), Lei Liang(Zhejiang Provincial People's Hospital), Feng Shen(Second Military Medical University), Yongyi Zeng(Sun Yat-sen University), Wan Yee Lau(Chinese University of Hong Kong), Timothy M. Pawlik(The Ohio State University), Matteo Serenari(Azienda USL di Bologna), Han Wu(Peking University), Wei‐Min Gu(Harbin Medical University), Chao Li(Second Military Medical University), Hong Wang(Liuyang City Maternal and Child Health Hospital), Ya-Hao Zhou(Puer University), Ting‐Hao Chen(National Taiwan University), Mengchao Wu(Second Military Medical University), Myron Schwartz(Icahn School of Medicine at Mount Sinai), Ming-Da Wang(Second Military Medical University), Matteo Cescon(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola)
Cited by 86
Related Papers
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Focal Gains of <i>VEGFA</i> and Molecular Classification of Hepatocellular Carcinoma
|Cancer Research|2008|712